Evidence map›Paper›PMID 24650746›Full record

ArticleJournal of vascular surgery2014

Molecular diagnosis in vascular Ehlers-Danlos syndrome predicts pattern of arterial involvement and outcomes.

Sherene Shalhub, James H Black, Alana C Cecchi, Zhi Xu, Ben F Griswold, Hazim J Safi, Dianna M Milewicz, Nazli B McDonnell

Open access · greenAbstract read
In one paragraph

Article in Journal of vascular surgery, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 5 pooled it
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 5 syntheses or guidelines pooled it, 127 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Guideline
  5. Guideline
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Iliac artery aneurysm endoleak management in a patient with vascular Ehlers-Danlos syndrome.Journal of vascular surgery cases and innovative techniques · 2024
    Article
  19. Case report: A novelFrontiers in medicine · 2024
    Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Sherene ShalhubDivision of Vascular Surgery, Department of General Surgery, University of Washington, Seattle, Wash. Electronic address: shalhub@uw.edu.
James H BlackDivision of Vascular Surgery and Endovascular Therapy, Department of Surgery, The Johns Hopkins Hospital, Baltimore, Md.
Alana C CecchiDivision of Medical Genetics, Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, Tex.
Zhi XuNational Institute on Aging, Baltimore, Md.
Ben F GriswoldNational Institute on Aging, Baltimore, Md.
Hazim J SafiDepartment of Cardiothoracic and Vascular Surgery, University of Texas Medical School at Houston, Houston, Tex.
Dianna M MilewiczDivision of Medical Genetics, Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, Tex.
Nazli B McDonnellNational Institute on Aging, Baltimore, Md.
National Institute on Aging · USThe University of Texas Health Science Center at Houston · USJohns Hopkins Hospital · USUniversity of Washington · US

Funding

U OF TEXAS HLTH SCI CTR HOUSTON CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCESUL1RR024148 · NCRR · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 2006 to 2010
$27.9M
Genetic Predisposition To Thoracic Aortic Aneurysms/DissectionsR01HL109942 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MILEWICZ, DIANNA M · 2012 to 2023
$7.5M
NCRR NIH HHS UL1 RR024148NCRR NIH HHS UL1-RR-024148NHLBI NIH HHS R01 HL109942NHLBI NIH HHS R01-HL-109942-01A1
6 · The paper itself

Abstract

objectiveThe management of arterial pathology in individuals with vascular Ehlers-Danlos syndrome (vEDS) remains a challenge. Here we describe the correlation between COL3A1 gene mutation type and the clinical phenotype in individuals with vEDS.

methodsIndividuals with confirmed molecular diagnoses of vEDS were enrolled in a multi-institutional natural history study. Data collected included demographics, clinical and family histories, arterial pathology (aneurysm, dissection, and rupture), operative details, and autopsy reports. Individuals were classified into two cohorts by the type of COL3A1 mutations and their effect on the amount of normal collagen produced: those with mutations that lead to minimal (MIN) production (10%-15%) of normal type III collagen and those with haploinsufficiency (HI) mutations that lead to production of 50% of the normal type III collagen.

resultsA cohort of 68 individuals (72%) from 56 families had arterial pathology (44% male) with 13% HI. The HI group was older at the time of their first vascular event (mean, 42 [range, 26-58] years vs 33 [range, 8-62] years; P = .016) and had a higher incidence of aortic pathology than the MIN group (56% vs 21%; P = .025). Visceral arterial pathology was seen in 43 arteries in 23 individuals in the MIN group vs only one artery in five individuals in the HI group. Emergency surgical procedures were more likely to be undertaken when vEDS diagnosis was not known (81% vs 41%; P = .005), and 81% of these procedures were open surgical repair compared with 19% endovascular repairs (P = .019). Open and endovascular repairs were equally used in the elective setting. Postoperative complications were highest when the diagnosis of vEDS was not known (62% vs 14%; P < .001) and when procedures were undertaken in an emergency setting (5% vs 55% P < .001). Mortality due to arterial complications was 0% in the HI cohort and 21% in the MIN cohort (P = .132).

conclusionsArterial pathology in vEDS individuals is related to the underlying COL3A1 mutation type. The arterial pathology in individuals with HI mutations occurs at later ages with a higher incidence of aortic disease compared with other COL3A1 mutation types. Molecular diagnosis is recommended because diagnosis confirmation, appropriate surveillance, and prophylactic interventions in an elective setting improve surgical outcomes.

Indexed as

AdolescentAdultAneurysm, RupturedAngioplastyAortic AneurysmAortic DissectionCeliac ArteryChildCollagen Type IIIEhlers-Danlos SyndromeEmergenciesFemaleGenetic TestingGenotypeHepatic ArteryHumansCOL3A1 protein, humanCollagen Type III

Identifiers

PMID24650746
PMCPMC4396069
OpenAlexW2084533380

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.